repaglinide, a new oral hypoglycemic for type 2 diabetes

Novo Nordisk is now marketing repaglinide, a new oral hypoglycemic for type 2 diabetes.

It's called GlucoNorm in Canada...and Prandin in the U.S.

This new drug is approved for use by itself...or in combination with metformin (Glucophage).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote